DNM2(动力蛋白2)是一种编码动力蛋白2的基因,属于动力蛋白(Dynamin)基因家族。动力蛋白家族是一类GTP酶,主要参与膜重塑和囊泡运输过程,尤其是内吞作用。DNM2在细胞内主要调控网格蛋白介导的内吞作用,帮助细胞膜形成囊泡并完成物质运输。此外,DNM2还参与细胞骨架重组、细胞分裂和突触小泡的循环等过程。DNM2蛋白由多个功能域组成,包括GTP酶结构域、中间结构域和PH结构域,这些结构域使其能够结合膜脂质并介导膜裂变。DNM2基因突变可能导致功能异常,与多种疾病相关,最常见的是显性遗传性轴索性周围神经病(CMT2M)和中心核肌病(CNM)。这些突变通常影响GTP酶活性或蛋白稳定性,导致神经或肌肉功能障碍。DNM2过表达可能增强内吞作用,但也会干扰正常膜运输,导致细胞功能紊乱,如突触传递异常或细胞分裂缺陷。相反,DNM2表达降低会抑制内吞作用,影响营养摄取和信号转导,可能导致神经退行性疾病或免疫缺陷。DNM2与其他动力蛋白家族成员(如DNM1和DNM3)具有相似的结构和功能,但组织分布和具体作用有所不同。DNM1主要在神经元中表达,参与突触小泡回收,而DNM3在睾丸和大脑中发挥作用。DNM2则在多种组织中广泛表达,尤其在肌肉和神经系统中起关键作用。研究表明,DNM2还与某些癌症相关,如乳腺癌和胶质母细胞瘤,可能通过调控细胞迁移和侵袭发挥作用。此外,DNM2在病毒感染过程中也扮演重要角色,某些病毒利用DNM2介导的内吞作用进入宿主细胞。因此,DNM2不仅是细胞基本功能的关键调控因子,也是多种疾病的潜在治疗靶点。
Dynamins represent one of the subfamilies of GTP-binding proteins. These proteins share considerable sequence similarity over the N-terminal portion of the molecule, which contains the GTPase domain. Dynamins are associated with microtubules. They have been implicated in cell processes such as endocytosis and cell motility, and in alterations of the membrane that accompany certain activities such as bone resorption by osteoclasts. Dynamins bind many proteins that bind actin and other cytoskeletal proteins. Dynamins can also self-assemble, a process that stimulates GTPase activity. Five alternatively spliced transcripts encoding different proteins have been described. Additional alternatively spliced transcripts may exist, but their full-length nature has not been determined. [provided by RefSeq, Jun 2010]
Dynamins表示GTP结合蛋白的亚家族中的一个。这些蛋白质共享在分子,其包含GTP酶结构域的N端部分相当的序列相似性。 Dynamins与微管有关。他们已牵涉在细胞过程,如细胞内吞作用和细胞运动,并在伴随某些活动,例如由破骨细胞的骨吸收的膜的改变。 Dynamins绑定结合肌动蛋白和其他细胞骨架蛋白许多蛋白质??。 Dynamins也自我组装,刺激GTP酶活的方法。五个编码不同蛋白可变剪接转录物已有描述。附加可变剪接转录物可能存在,但它们的全长性质尚未确定。 [由RefSeq的,2010年6月提供]
DNM2基因(以及对应的蛋白质)的细胞分布位置:
DNM2基因的本体(GO)信息:
名称 |
---|
4144 Endocytosis [PATH:hsa04144] |
4666 Fc gamma R-mediated phagocytosis [PATH:hsa04666] |
4961 Endocrine and other factor-regulated calcium reabsorption [PATH:hsa04961] |
4721 Synaptic vesicle cycle [PATH:hsa04721] |
5100 Bacterial invasion of epithelial cells [PATH:hsa05100] |
名称 |
---|
Adaptive Immune System |
Axon guidance |
Clathrin derived vesicle budding |
Developmental Biology |
eNOS activation and regulation |
Formation of annular gap junctions |
Gap junction degradation |
Gap junction trafficking |
Gap junction trafficking and regulation |
Golgi Associated Vesicle Biogenesis |
Immune System |
Innate Immune System |
L1CAM interactions |
Lysosome Vesicle Biogenesis |
Membrane Trafficking |
Metabolism |
Metabolism of nitric oxide |
MHC class II antigen presentation |
NGF signalling via TRKA from the plasma membrane |
NOSTRIN mediated eNOS trafficking |
Recycling pathway of L1 |
Retrograde neurotrophin signalling |
Signal Transduction |
Signalling by NGF |
Toll Like Receptor 4 (TLR4) Cascade |
Toll-Like Receptors Cascades |
trans-Golgi Network Vesicle Budding |
Vesicle-mediated transport |
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B (disorder) | 0.48 | 3 | 0 | CLINVAR_CTD_human_ORPHANET_UNIPROT |
Myopathy, Centronuclear, Autosomal Dominant | 0.36 | 9 | 4 | CLINVAR_CTD_human_UNIPROT |
LETHAL CONGENITAL CONTRACTURE SYNDROME 5 | 0.36 | 1 | 1 | CLINVAR_ORPHANET_UNIPROT |
Congenital Structural Myopathy | 0.1382164 | 38 | 0 | BeFree_CTD_human_LHGDN |
Charcot-Marie-Tooth Disease | 0.130877538 | 20 | 1 | BeFree_CLINVAR_LHGDN |
X-linked centronuclear myopathy | 0.120542884 | 2 | 1 | BeFree_CLINVAR |
POLYCYSTIC KIDNEY DISEASE 1 | 0.08 | 0 | 0 | MGD |
Centronuclear myopathy | 0.010857675 | 40 | 0 | BeFree |
Alzheimer's Disease | 0.008087174 | 2 | 0 | BeFree_GAD_LHGDN |
Malignant neoplasm of breast | 0.002909916 | 3 | 0 | BeFree_GAD |
关注微信订阅号,实时查看信息,关注医学生物学动态。